All these findings together with the negative association between BMI and serum ZAG levels suggest that ZAG is closely linked to obesity, not only in simple overweight/obese patients, but also in PCAD patients. Here, AZGP1 is linked to obesity due to melanocortin 4 receptor deficiency.